‹ ›
MYP_101937
Basic Information
C41 [S15X](S15C)
Antimicrobial
Antiviral
Antiviral ▸ Anti-HIV ▸ Anti-HIV-1
Antiviral ▸ Antiviral mechanism ▸ Viral fusion inhibition
not Standard
41 amino acids
-
contains X representing unresolved or non-standard residue
Sequence
EWDREINNYTSLIHXLIEESQNQQEKNEQELLELDKWASLW
Physicochemical Analysis
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available

Not available: incomplete physicochemical profile.

Molecular Weight
Not available
Isoelectric Point (pI)
Not available
Net Charge (pH 7.0)
Not available
GRAVY Index
Not available
Boman Index
Not available
Instability Index
Not available
The radar chart requires all six dimensions. Available values are listed above; missing values are not plotted as zero.
Residue Composition
Amino Acid Composition
Chemical Descriptors
Structural Visualization
3D PDB MODEL
Readable PDBLast file check: 2026-11-18T18:17:39.357169+00:00. File readability does not guarantee 3D display.
Match index: Listed
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0019287 REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
noncanonical or undefined residue-containing peptide [Modified]
None
None
PEG2000 conjugated to cysteine substituted at position 15
Bio-Activity Profile
Antiviral Anti-HIV-1 Fusion inhibition
HIV-1 gp41; CHO-WT cells; K562 cells
0.005±0.0005 μM
IC50 (cell-cell fusion inhibition assay)
RECORD: Rec_0034079 REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
noncanonical or undefined residue-containing peptide [Modified]
None
None
PEG750 conjugated to cysteine substituted at position 15
Bio-Activity Profile
Antiviral Anti-HIV-1 Fusion inhibition
HIV-1 gp41; CHO-WT cells; K562 cells
0.0041±0.001 μM
IC50 (cell-cell fusion inhibition assay)
RECORD: Rec_0281488 REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Cathelicidin
32630
Structure & Mods
linear peptide [Linear]
noncanonical or undefined residue-containing peptide [Modified]
PEG conjugated to cysteine substituted at position 15; PEG chain length unresolved in this CAMP record
Bio-Activity Profile
Antiviral Anti-HIV-1 Fusion inhibition
HIV-1 gp41; CHO-WT cells; K562 cells
IC50 (cell-cell fusion inhibition assay)
RECORD: Rec_0341471 REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
HR2 fusion-inhibitory peptide
32630
Structure & Mods
linear peptide [Linear]
modified L-amino-acid peptide [Modified]
None
None
PEG750 conjugated to cysteine substituted at position 15
Bio-Activity Profile
Antiviral Anti-HIV-1 Fusion inhibition
HIV-1 gp41; CHO-WT cells; K562 cells
0.0041±0.001 μM
IC50 (cell-cell fusion inhibition assay)
Mammalian: 1 h; Yeast: 30 min; E. coli: >10 h
RECORD: Rec_0360086 REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
HR2 fusion-inhibitory peptide
32630
Structure & Mods
linear peptide [Linear]
modified L-amino-acid peptide [Modified]
None
None
PEG2000 conjugated to cysteine substituted at position 15
Bio-Activity Profile
Antiviral Anti-HIV-1 Fusion inhibition
HIV-1 gp41; CHO-WT cells; K562 cells
0.005±0.0005 μM
IC50 (cell-cell fusion inhibition assay)
Mammalian: 1 h; Yeast: 30 min; E. coli: >10 h